Nuveen Core Plus Impact Fund

Market Movers (8-K)

NYSE
Nuveen Core Plus Impact Fund's annual meeting saw the election of preferred share trustees but failed to elect Class III Trustees, who will remain in their roles until the next annual meeting.
Delay expected
Worse than expected
NYSE
Nuveen Core Plus Impact Fund's Board of Trustees has adopted amended by-laws to remove control share provisions, effective February 28, 2024.

Insider Trading (Form 4)

NYSE
Saba Capital Management, along with Boaz Weinstein, reported selling shares of Nuveen Core Plus Impact Fund, reducing their holdings.
NYSE
Saba Capital Management, a significant shareholder, has sold a portion of its holdings in Nuveen Core Plus Impact Fund.
NYSE
Saba Capital Management, L.P. sold 34,247 shares of Nuveen Core Plus Impact Fund at $11.36 per share, reducing their holdings to 2,975,868 shares.
NYSE
Saba Capital Management, a 10% owner and director of Nuveen Core Plus Impact Fund, sold 46,598 shares of common stock at $11.33 per share on November 29, 2024.
NYSE
Saba Capital Management, along with Boaz Weinstein, reported selling shares of Nuveen Core Plus Impact Fund, reducing their holdings.
Worse than expected
NYSE
Saba Capital Management, L.P. sold 45,356 shares of Nuveen Core Plus Impact Fund at $11.32 per share, reducing their holdings to 3,129,252 shares.

Proxy Statements (Def-14A)

NYSE
Nuveen funds have scheduled a virtual annual meeting on April 17, 2025, to elect board members and address other business matters.
NYSE
Nuveen Core Plus Impact Fund urges shareholders to vote against Saba Capital Management's nominee, claiming Saba's interests are not aligned with those of the fund's investors.
NYSE
Nuveen Core Plus Impact Fund urges shareholders to vote for its board nominees amidst a proxy battle with Saba Capital Management, who is attempting to appoint a new trustee.
NYSE
Nuveen Core Plus Impact Fund (NPCT), Nuveen Variable Rate Preferred & Income Fund (NPFD), Nuveen Multi-Asset Income Fund (NMAI) and Nuveen Real Asset Income and Growth Fund (JRI) have adjourned their annual shareholder meetings to May 31, 2024, to allow for further solicitation of shareholder votes.
Delay expected
NYSE
Glass Lewis, a leading independent proxy advisory firm, recommends shareholders vote for Nuveen's board nominees, rejecting Saba Capital's nominee for several Nuveen closed-end funds.
NYSE
Nuveen Core Plus Impact Fund urges shareholders to vote for its Board nominees amidst a challenge from Saba Capital, who is seeking to replace a trustee.

Schedule 13D - Activist Investments

NYSE
Saba Capital Management, L.P. and its affiliates have reduced their beneficial ownership in Nuveen Core Plus Impact Fund to 4.93% through a series of open market sales.
NYSE
Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 8 to their Schedule 13D, disclosing a beneficial ownership of 6.08% in Nuveen Core Plus Impact Fund following a series of open market share sales.
Worse than expected
NYSE
Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 7 to their Schedule 13D, disclosing a reduction in their beneficial ownership of Nuveen Core Plus Impact Fund to 7.14% through a series of open market sales.
Worse than expected
NYSE
Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 6 to their Schedule 13D, revealing a current beneficial ownership of 8.22% in Nuveen Core Plus Impact Fund and detailing recent open market sales of shares.

Schedule 13G - Passive Investments

NYSE
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.89% in Nuveen Core Plus Impact Fund.
NYSE
Morgan Stanley and its subsidiary, Parametric Portfolio Associates LLC, reported a combined 8.0% beneficial ownership in Nuveen Core Plus Impact Fund as of December 31, 2025.
NYSE
Morgan Stanley and its subsidiary, Parametric Portfolio Associates LLC, have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 9.0% in Nuveen Core Plus Impact Fund.
NYSE
Morgan Stanley and its wholly-owned subsidiary, Parametric Portfolio Associates LLC, have jointly disclosed a beneficial ownership of 7.3% in Nuveen Core Plus Impact Fund, totaling 2,109,660 common shares.